Stevenson J D, Doxey R, Abudu A, Parry M, Evans S, Peart F, Jeys L
Royal Orthopaedic Hospital, The Woodlands, Birmingham, Aston University Medical School, Aston Express Way, Birmingham, B4 7ET, UK.
University of Birmingham Medical School, Birmingham, UK.
Bone Joint J. 2018 Apr 1;100-B(4):535-541. doi: 10.1302/0301-620X.100B4.BJJ-2017-0830.R1.
Preserving growth following limb-salvage surgery of the upper limb in children remains a challenge. Vascularized autografts may provide rapid biological incorporation with the potential for growth and longevity. In this study, we aimed to describe the outcomes following proximal humeral reconstruction with a vascularized fibular epiphyseal transfer in children with a primary sarcoma of bone. We also aimed to quantify the hypertrophy of the graft and the annual growth, and to determine the functional outcomes of the neoglenofibular joint.
We retrospectively analyzed 11 patients who underwent this procedure for a primary bone tumour of the proximal humerus between 2004 and 2015. Six had Ewing's sarcoma and five had osteosarcoma. Their mean age at the time of surgery was five years (two to eight). The mean follow-up was 5.2 years (1 to 12.2).
The overall survival at five and ten years was 91% (confidence interval (CI) 95% 75% to 100%). At the time of the final review, ten patients were alive. One with local recurrence and metastasis died one-year post-operatively. Complications included seven fractures, four transient nerve palsies, and two patients developed avascular necrosis of the graft. All the fractures presented within the first postoperative year and united with conservative management. One patient had two further operations for a slipped fibular epiphysis of the autograft, and a hemi-epiphysiodesis for lateral tibial physeal arrest. Hypertrophy and axial growth were evident in nine patients who did not have avascular necrosis of the graft. The mean hypertrophy index was 65% (55% to 82%), and the mean growth was 4.6 mm per annum (2.4 to 7.6) in these nine grafts. At final follow-up, the mean modified functional Musculoskeletal Tumour Society score was 77% (63% to 83%) and the mean Toronto Extremity Salvage Score (TESS) was 84% (65% to 94%).
Vascularized fibular epiphyseal transfer preserves function and growth in young children following excision of the proximal humerus for a malignant bone tumour. Function compares favourably to other limb-salvage procedures in children. Longer term analysis is required to determine if this technique proves to be durable into adulthood. Cite this article: Bone Joint J 2018;100-B:535-41.
在儿童上肢保肢手术后维持生长仍然是一项挑战。带血管蒂自体移植可能会实现快速生物融合,并具有生长和长期存活的潜力。在本研究中,我们旨在描述采用带血管蒂腓骨骨骺转移对原发性骨肉瘤患儿进行肱骨近端重建后的结果。我们还旨在量化移植骨的肥大情况和年度生长情况,并确定新肩锁关节的功能结果。
我们回顾性分析了2004年至2015年间因肱骨近端原发性骨肿瘤而接受该手术的11例患者。其中6例为尤因肉瘤,5例为骨肉瘤。他们手术时的平均年龄为5岁(2至8岁)。平均随访时间为5.2年(1至12.2年)。
5年和10年的总生存率为91%(置信区间(CI)95% 75%至100%)。在最后一次复查时,10例患者存活。1例出现局部复发和转移的患者术后1年死亡。并发症包括7例骨折、4例短暂性神经麻痹,2例患者发生移植骨缺血性坏死。所有骨折均在术后第一年内出现,经保守治疗后愈合。1例患者因自体移植腓骨骨骺滑脱又接受了两次手术,以及因胫骨外侧骨骺阻滞进行了半骨骺阻滞术。9例未发生移植骨缺血性坏死的患者出现了肥大和轴向生长。这9例移植骨的平均肥大指数为65%(55%至82%),平均每年生长4.6毫米(2.4至7.6毫米)。在最后随访时,改良的肌肉骨骼肿瘤学会平均功能评分为77%(63%至83%),多伦多肢体挽救评分(TESS)平均为84%(65%至94%)。
对于因恶性骨肿瘤切除肱骨近端的幼儿,带血管蒂腓骨骨骺转移可保留功能并维持生长。其功能与儿童其他保肢手术相比具有优势。需要进行长期分析以确定该技术在成年期是否耐用。引用本文:《骨与关节杂志》2018年;100 - B:535 - 41。